Influence of PAC, a Curcumin Analog Inhibitor of NF-κB, on the Radiosensitivity of Breast Tumor Cells
Preprint
- 17 February 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The search for NF-κB blockers to optimize antioxidants and counteract inflammation and carcinogenesis has identified several promising natural compounds, encompassing curcumin. Nonetheless, despite the pleiotropic health attributes of curcumin and established safety, its in vivo efficacy is limited by its poor pharmacokinetic properties, primarily due to its low bioavailability because of its low free serum concentrations and short half-life. To overcome these restrictions, we investigated the efficacy of the synthetic curcumin analog PAC in breast cancer cells. Additionally, MCF-7 and MDA-MB-231 cell lines were employed to explore the anticancer effects of PAC by assessing cell viability, apoptosis, clonogenic survival, and the expression of NF-κB, p53, Bcl-2, and Bax. Our results validate that PAC effectively inhibits cell proliferation and induces apoptosis in a dose-dependent manner. PAC also significantly enhances the radiosensitivity of breast cancer cells, indicating a potential synergistic effect with radiation therapy. Mechanistically, PAC exerts anticancer effects by inhibiting NF-κB signaling and modulating apoptotic genes like p53, Bax, and Bcl-2. These findings highlight its potential as a breast cancer therapeutic, enhancing existing treatments.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectivesBiomedicine & Pharmacotherapy, 2023
- P53, GHRH, inflammation and cancerEBioMedicine, 2018
- Cancer and inflammationWIREs Mechanisms of Disease, 2016
- PAC exhibits potent anti‐colon cancer properties through targeting cyclin D1 and suppressing epithelial‐to‐mesenchymal transitionMolecular Carcinogenesis, 2015
- Mutant p53 and the Response to Chemotherapy and Radiation2014
- Measurement of Cell Death in Mammalian CellsCurrent Protocols in Pharmacology, 2012
- Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcuminBioorganic & Medicinal Chemistry, 2010
- PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cellsBreast Cancer Research and Treatment, 2010
- Synthesis of Curcumin Analogues as Potential Antioxidant, Cancer Chemopreventive AgentsArchiv der Pharmazie, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001